Development of novel transsynaptic tracers for use in the central nervous system
Development of novel transsynaptic tracers for use in the central nervous system
批准号:
9268809
负责人:
CONSTANCE L CEPKO
金额:
$36.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2019-04-30
关键词:
AmphibiaAnatomyAnimal ModelAreaBiological AssayBirdsCommunicationComplexDevelopmentDiseaseDyesElectron MicroscopyEngineeringEnterobacteria phage P1 Cre recombinaseFishesG-substrateGTP-Binding ProteinsGene TransferGenesGenomeGlycoproteinsGoalsHealthHippocampus (Brain)InfectionInterneuronsKnowledgeLabelLaboratoriesLearningMapsMethodsMonkeysMusNervous System PhysiologyNervous system structureNeuraxisNeuronsOrganismPhysiologicalPreparationProteinsRabies virusReagentRetinaSafetySeriesSynapsesTestingToxic effectTracerTransgenic MiceVariantVesicular stomatitis Indiana virusViralViral VectorVirusVirus-like particlebasecell typedesignin vivomad itch virusnervous system disorderneurotropic virusnovelparticlepublic health relevancereceptortooltransmission processvector
中文摘要
描述(由申请人提供):中枢神经系统(CNS)神经元之间的连接映射是神经科学家长期以来的目标。对这些联系的了解将帮助我们理解神经系统在健康和疾病中的功能。染料标记、生理记录、电子显微镜水平的解剖以及蛋白质的转移都被用于跟踪突触连接。嗜神经病毒也被使用,利用它们在神经元之间传播的能力。病毒示踪剂提供了更高通量的希望,并且可以通过其基因转移能力扩展检测的曲目,而不仅仅是定位连接。我们最近开发了水疱性口炎病毒(VSV)作为跨突触示踪剂。该病毒与先前开发的跨突触病毒、狂犬病毒(RABV)和伪狂犬病毒(PRV)相比具有若干优势。RABV是一种致命病毒,这限制了它在实验室中的使用。PRV有一个庞大而复杂的基因组,因此很难以直接的方式对其进行工程设计。VSV具有相对简单的基因组,与RABV非常相似。它是非常好的特点,因为它迅速增长到高滴度,并有长期的跟踪记录的安全在实验室。我们发现VSV可以在小鼠、猴子和其他多种物种(包括鸟类、两栖动物和鱼类)中通过突触传播。此外,我们发现我们可以创建特异性逆行或特异性顺行传播的VSV载体。方向性完全取决于病毒包膜糖蛋白,由病毒G基因编码。我们建议创建一系列跨突触病毒示踪剂,这将对研究不同生物体和神经系统不同区域的神经科学家有用。我们将首先探索VSV与不同病毒G蛋白的使用,将我们所学到的应用于设计特定的顺行和逆行示踪剂。我们希望扩大G蛋白的范围,不仅可以用于VSV,还可以用于其他示踪剂。我们还建议利用我们已经为VSV开发的一些工具,开发一种替代的无毒病毒作为示踪剂。最后,我们建议开发一种示踪剂,虽然基于病毒,但实际上不是病毒,而是一种载体,可以将Cre重组酶移动到突触之间,以绘制连接的神经元。与VSV, RABV或PRV相比,这些替代策略提供了降低毒性的希望,以及可以与工程小鼠系或其他模式生物相结合的其他特征。
英文摘要
DESCRIPTION (provided by applicant): The mapping of connections among central nervous system (CNS) neurons is a longstanding goal of neuroscientists. Knowledge of the connections will inform our understanding of the function of the nervous system, in both health and disease. Dye labeling, physiological recordings, anatomy at the level of electron microscopy, and the transfer of proteins have all been used to track synaptic connections. Neurotropic viruses have also been used, taking advantage of their ability to spread among neurons. Viral tracers offer the promise of higher throughput, and can expand the repertoire of assays beyond mapping connections, via their gene transfer capabilities. We have recently developed vesicular stomatitis virus (VSV) as a transsynaptic tracer. This virus has several advantages over the previously developed transsynaptic viruses, rabies virus (RABV) and pseudorabies virus (PRV). RABV is a lethal virus, which limits its use in the laboratory. PRV has a large and complex genome, making it difficult to engineer in a straightforward manner. VSV has a relatively simple genome, very similar to that of RABV. It is very well characterized as it rapidly grows to high titr and has a long track record for safety in the laboratory. We found that VSV can transmit transsynaptically in mice, monkeys, and multiple other species, including birds, amphibians, and fish. Moreover, we found that we could create VSV vectors that could transmit specifically retrogradely or specifically anterogradely. The directionality was entirely dependent upon the viral envelope glycoprotein, encoded by a viral G gene. We propose to create a series of transsynaptic viral tracers that will be useful to neuroscientists working in different organisms and different areas of the nervous system. We will first explore the use of VSV with different viral G proteins, applying what we learn to the design of specific anterograde and retrograde tracers. We hope to expand the repertoire of G proteins that can be used not only with VSV, but with other tracers as well. We also propose to develop an alternative non-toxic virus for use as a tracer, using some of the tools that we have already developed for VSV. Finally, we propose to develop a tracer that, although based upon a virus, is actually not a virus, but a vehicle to move Cre recombinase across synapses to map connected neurons. These alternative strategies offer the promise of reduced toxicity, relative to VSV, RABV, or PRV, as well as other features that can be combined with engineered lines of mice, or other model organisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AAV Induced Toxicity in the Eye
-
批准号:10596582
-
项目类别:
-
资助金额:$41.64万
-
财政年份:2019
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Determination of Cone Photoreceptor Fate
-
批准号:10320020
-
项目类别:
-
资助金额:$40.41万
-
财政年份:2019
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Determination of Cone Photoreceptor Fate
-
批准号:10539248
-
项目类别:
-
资助金额:$41.66万
-
财政年份:2019
-
负责人:CONSTANCE L CEPKO
-
依托单位:
AAV Induced Toxicity in the Eye
-
批准号:9902496
-
项目类别:
-
资助金额:$41.64万
-
财政年份:2019
-
负责人:CONSTANCE L CEPKO
-
依托单位:
AAV Induced Toxicity in the Eye
-
批准号:10378079
-
项目类别:
-
资助金额:$40.6万
-
财政年份:2019
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Gene Therapy for Alzheimer's Disease
-
批准号:9761945
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2018
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Neural circuits in zebrafish: form, function and plasticity
-
批准号:9119539
-
项目类别:
-
资助金额:$176.8万
-
财政年份:2014
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Neural circuits in zebrafish: form, function and plasticity
-
批准号:8826324
-
项目类别:
-
资助金额:$173.64万
-
财政年份:2014
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Gene therapy to support cone metabolism in retinitis pigmentosa
-
批准号:8481698
-
项目类别:
-
资助金额:$42.33万
-
财政年份:2013
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Gene therapy to support cone metabolism in retinitis pigmentosa
-
批准号:8622203
-
项目类别:
-
资助金额:$41.53万
-
财政年份:2013
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Development of novel transsynaptic tracers for use in the central nervous system
-
批准号:8561299
-
项目类别:
-
资助金额:$37.08万
-
财政年份:2013
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Development of novel transsynaptic tracers for use in the central nervous system
-
批准号:8658163
-
项目类别:
-
资助金额:$36.71万
-
财政年份:2013
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Development of novel transsynaptic tracers for use in the central nervous system
-
批准号:9057146
-
项目类别:
-
资助金额:$36.9万
-
财政年份:2013
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Gene Expression Profiles of Retinal Degeneration
-
批准号:6569376
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2003
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Gene Expression Profiles of Retinal Degeneration
-
批准号:7171767
-
项目类别:
-
资助金额:$28.8万
-
财政年份:2003
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Gene Expression Profiles of Retinal Degeneration
-
批准号:7009201
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2003
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Gene Expression Profiles of Retinal Degeneration
-
批准号:6696236
-
项目类别:
-
资助金额:$29.53万
-
财政年份:2003
-
负责人:CONSTANCE L CEPKO
-
依托单位:
Gene Expression Profiles of Retinal Degeneration
-
批准号:6848024
-
项目类别:
-
资助金额:$29.66万
-
财政年份:2003
-
负责人:CONSTANCE L CEPKO
-
依托单位:
GENE EXPRESSION IN SINGLE, IDENTIFIED CNS CELLS
-
批准号:6180017
-
项目类别:
-
资助金额:$33.52万
-
财政年份:1999
-
负责人:CONSTANCE L CEPKO
-
依托单位:
GENE EXPRESSION IN SINGLE IDENTIFIED CNS CELLS
-
批准号:6051791
-
项目类别:
-
资助金额:$40.0万
-
财政年份:1999
-
负责人:CONSTANCE L CEPKO
-
依托单位:
海外基金